Pelham Manor, NY, United States of America

Stanley G Nathenson


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Stanley G. Nathenson: A Pioneer in Type 1 Diabetes Research

Introduction

Stanley G. Nathenson is a notable inventor based in Pelham Manor, NY, whose work focuses on the intricate relationship between antigen presentation and type 1 diabetes. With his innovative insights and contributions, he enhances our understanding of autoimmune diseases and their underlying mechanisms.

Latest Patents

Nathenson holds a significant patent titled "Antigens targeted by prevalent pathogenic T cells in type 1 diabetes and uses thereof." This invention identifies a crucial ligand of CD8 T cells involved in type 1 diabetes, specifically the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP). The patent details several CD8 T cell-binding peptides derived from IGRP, which have important implications for the diagnosis and treatment of autoimmune diabetes. These innovations include various oligopeptide and polypeptide compositions designed to bind human MHC class I molecules, offering potential therapeutic avenues for preventing or treating type 1 diabetes.

Career Highlights

Throughout his career, Stanley G. Nathenson has been affiliated with esteemed institutions, including Albert Einstein College of Medicine and the University of Virginia. His work in these organizations has greatly contributed to the field of immunology and diabetes research, solidifying his reputation as a forward-thinking inventor.

Collaborations

Nathenson has collaborated with other prominent professionals in his field, including Teresa P. DiLorenzo and Anne M. Evans. These partnerships demonstrate his commitment to interdisciplinary research and the advancement of scientific knowledge related to autoimmune conditions.

Conclusion

Stanley G. Nathenson’s contributions to the field of type 1 diabetes research through his innovative patent exemplify the vital role of inventors in addressing medical challenges. His work not only advances scientific understanding but also opens new pathways for treatment, underscoring the importance of sustained innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…